Dr. John Wallenburg
Chief Scientific Officer, Cystic Fibrosis Canada
Dr. John Wallenburg joined Cystic Fibrosis Canada as Chief Scientific Officer in 2015. He oversees the five mission programs of the organization: research, healthcare, advocacy, the Canadian CF registry, and CF CanACT, the clinical trial network launched in 2018. Inspired by the diagnosis of his daughter he spent the last 35 years at the interface of academic invention and commercialization. At OICR he helped launch the investment program (now FACIT), and at McGill he managed life sciences technology transfer. He’s been a research scientist, product manager, and biotech startup co-founder, executive and board member. John is also a CF parent.